You are here
EYERX RESEARCH, INC.
UEI: N/A
# of Employees: N/A
HUBZone Owned: No
Socially and Economically Disadvantaged: No
Woman Owned: No
Award Charts
Award Listing
-
A Thermo-responsive Biopharmaceutical to Enhance the Tear Production of Lacritin
Amount: $146,388.00Project Summary/Abstract Ocular pharmaceuticals predominantly use the topical route of administration, which involves a number of benefits and limitations when compared to systemic drug routes. A majo ...
STTRPhase I2013Department of Health and Human Services National Institutes of Health -
PROOF OF CONCEPT FOR ANTIMICROBIAL PROPERTIES OF LACRITIN IN VIVO
Amount: $128,842.00DESCRIPTION (provided by applicant): Over the past sixty years, antibiotics have comprised a key component in both the treatment and prophylaxis of bacterial infections. Since that time the continuous ...
STTRPhase I2010Department of Health and Human Services National Institutes of Health -
Stimulation of Tear Secretion by a Novel Glycoprotein
Amount: $319,222.00DESCRIPTION (provided by applicant): Description Dry eye is a ubiquitous, often overlooked, under diagnosed and poorly understood affliction of the ocular surface. As a multifactorial disease, dry eye ...
STTRPhase II2007Department of Health and Human Services National Institutes of Health -
Stimulation of Tear Secretion by a Novel Glycoprotein
Amount: $104,857.00DESCRIPTION (provided by applicant): Dry eye is a ubiquitous, often overlooked, underdiagnosed and poorly understood affliction of the ocular surface. This common opthalmological complaint can markedl ...
STTRPhase I2004Department of Health and Human Services National Institutes of Health -
Stimulation of Tear Secretion by a Novel Glycoprotein
Amount: $104,857.00DESCRIPTION (provided by applicant): Dry eye is a ubiquitous, often overlooked, underdiagnosed and poorly understood affliction of the ocular surface. This common opthalmological complaint can markedl ...
SBIRPhase I2004Department of Health and Human Services National Institutes of Health
